Диссертация (Анатомо-экспериментальное обоснование нового способа наложения спленоренального анастомоза при портальной гипертензии), страница 21
Описание файла
Файл "Диссертация" внутри архива находится в папке "Анатомо-экспериментальное обоснование нового способа наложения спленоренального анастомоза при портальной гипертензии". PDF-файл из архива "Анатомо-экспериментальное обоснование нового способа наложения спленоренального анастомоза при портальной гипертензии", который расположен в категории "". Всё это находится в предмете "медицина" из Аспирантура и докторантура, которые можно найти в файловом архиве МГМУ им. Сеченова. Не смотря на прямую связь этого архива с МГМУ им. Сеченова, его также можно найти и в других разделах. , а ещё этот архив представляет собой кандидатскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени кандидата медицинских наук.
Просмотр PDF-файла онлайн
Текст 21 страницы из PDF
Surg. –2006. - Vol. 243, №6. – Р.884-892.244.Luca, A. Effects of endtoside portacaval shunt and distal splenorenal shunt onsystemic and pulmonary haemodynamics in patients with cirrhosis / A.Luca [etal.] // Gastroenterol. Hepatol. – 1999. – Vol. 14, № 11. – P. 1112- 1118.245.Luqman, Z. An analysis of surgical shunts for the management of portalhypertension at Aga Khan University Hospital / Z.Luqman, M.R.Khan, М.Alamet al.
// J. Ayub. Med. Coll. Abbottabad. –2004. – Vol. 16, №4. – Р. 70-74.246.Marion, P. Anastomose spleno-renale, mesentericocave pour obstructionsportales extrahepatiques / P.Marion // J. De Chir. - 1958. - Vol. 76, №5. - P. 658.247.Marion, P. Mesentericocavael anastomoses / P.Marion // J. Cardiovascuul.surg. - 1965. - Suppl. 1, № 1. - P.70-81.248.McCormack, T.T. Gastric lesions in portal hypertension: inflammatorygastritis or congestive gastropathy? / T.T.
McCormack, J. Sims, I. Eyre-Brook etal. // Gut.- 1985.-Vol. 26, № 11. - P. 1226-1232.249.Merkel, C. Should we routinely measure portal pressure in patients withcirrhosis, using hepatic venous pressure gradient (HVPG) as guidance forprophylaxis and treatment of bleeding and re-bleeding? Yes! / C.Merkel,S.Montagnese // Eur. J. Int.
Med. - 2011.-Vol. 22, № 1.-P. 1-14.250.Mikkelsen, W. Portocaval shunt in cirrhosis of the liver / W.Mikkelsen,F.Turrill, A.Patisson // Amer. J. Surg. - 1962. - Vol. 104. - P. 204.251.Moller, S. Portal pressure should be measured on suspicion of portal131hypertension / S. Moller, F. Bendtsen // Ugeskrift Laeger. - 2010. - Vol. 172, №49. -P. 3411-3413.252.Montes-de-Oca,M.Haemodynamicderangementinhumanimmunodeficiency virus-infected patients with hepatitis C virus-relatedcirrhosis: the role of bacterial translocation / M.Montes-de-Oca, M.J.Blanco,M.Marquez et al.
// Liver Int. - 2011. -Vol. 31, № 6. - P. 850-858.253.Mukherjee, S. Comparison of indocyanine green clearance with Child's-Pughscore and hepatic histology: a multivariate analysis / S.Mukherjee, M.A.Rogers,B.Buniak // Hepatogastroenterology. - 2006. - Vol. 53, №67. - P. 120-123.254.Northup, P.G. Editorial: Beta-blockers and the prevention of decompensationin cirrhosis: worth the trouble / P.G.Northup, Z.H.Henry // Am. J. Gastroenterol.-2011- Vol. 107, № 3.
- P. 428-430.255.Nunez, M. Clinical syndromes and consequences of antiretroviral-relatedhepa- totoxicity / M.Nunez // Hepatology. - 2010. - Vol. 52, № 3. - P. 1143-1155.256.Paquet, K.J. Sclerotherapy for the prevention of bleeding esophageal varices /K.J. Paquet // Internist (Berl). - 1983. - Vol. 24, №2. - P.81-84.257.Park, D.K. Clinical significance of variceal hemorrhage in recent years inpatients with liver cirrhosis and esophageal varices / D.K.Park, S.H.Um, J.W.Leeet. al. // J.
Gastroenterol. Hepatol. - 2004. - Vol.19, №9. - P. 1024-1051.258.Peramau, J.M. Feasibility and long-term evolution of TIPS in cirrhoticpatients with portal thrombosis / J.M.Peramau, A.Baju, L.D’alteroche et al. //Eur. J. Gastroenterol. Hepatol. - 2010. - Vol. 22, № 9. - P. 1093-1098.259.Perrillo, R.P. Acute flares in chronic hepatitis B: the natural and unnaturalhistory of an immunologically mediated liver disease / R.P.Perrillo //Gastroenterology. - 2001. - Vol. 120.
- P. 1009-1022.260.Роса, M. Prognostic markers in patients with cirrhosis and portal hypertensionwho have not bled / M.Роса, A.Puente, I.Graupera, C.Villanueva // Dis. Markers.-2011.- Vol. 31, № 3. - P. 147-154.132261.Pulitano, C. Percutaneous RetroperitonealSplenorenal Shuntfor SymptomaticPortal Vein Thrombosis After Liver Transplantation / С.Pulitano, С.Rogan,С.Sandroussi et. al. // Am J Transplant. –2015. - Vol. 15(8). – Р. 2261-2264.262.Rikkers, L.F.
Emergency Shunt, Role in present Management of VaricealBleeding / L.F.Rikkers, G.Jin // Arch Surg. – 1995. - Vol. 130.- Р. 472-476.263.Ripoll, C. The management of portal hypertensive gastropathy and gastricantral vascular ectasia / C.Ripoll, G.Garcia-Tsao // Dig. Liver Dis. - 2011. - Vol.43, № 5. - P. 345-351.264.Robic, M.A. Liver stiffness accurately predicts portal hypertension relatedcomplications in patients with chronic liver disease: a prospective study /M.A.Robic, B.Procopet, S.Metivier et al. // J.
Hepatol. - 2011. - Vol. 55, № 5. - P.1017-1024.265.Romanelli, R.G. Elevated plasma levels of urotensin II do not correlate withsystemic haemodynamics in patients with cirrhosis / R.G.Romanelli, G.Laffi,F.Vizzutti et al. // Dig. Liver Dis. - 2011. - Vol. 43, № 4. - P. 314-318.266.Rosenkrantz, A.B. Magnetization transfer contrast-prepared MR imaging ofthe liver: inability to distinguish healthy from cirrhotic liver / A.B.Rosenkrantz,P.Storey, Р.Gilet et al. // Radiology. - 2012.
- Vol. 262, № 1. - P. 136-143.267.Sandblom, Ph. The History of portal hypertension / Ph.Sandblom // J. Roy.Soc. Med. - 1993. - Vol. 86, №9. - Р. 544-546.268.Scherlock, S. Esophageal varices / S.Scherlock // Am. J. Surg. – 1990. - Vol.160, №1. – Р. 9-13.269.Sethasine,S. Quantitative histological-hemodynamic correlations in cirrhosis/ S.Sethasine, D.Jain, R.J.Groszmann, G.Garcia-Tsao // Hepatology. - 2012. Vol. 55, № 4. - P.1146-1153.270.Sharara, A.I. Gastroesophageal variceal hemorrhage / A.I.Sharara,D.C.Rockey // N Engl J Med.
– 2001. - Vol. 345. – Р. 669-681.271.Steenkiste, C.V. Inhibition of placental growth factor activity reduces theseverity of fibrosis, inflammation, and portal hypertension in cirrhotic mice /C.V.Steenkiste, J.Ribera, A.Geerts et al. // Hepatology. -2011. - Vol. 53, № 5. -133P. 1629-1640.272.Steib, C.J.
Intraperitoneal LPS amplifies portal hypertension in rat liverfibrosis / C.J.Steib, A.C.Hartmann, C.Van Hesler et al. // Lab. Investig. - 2010. Vol. 90, № 7. - P. 1024-1032.273.Sporea, I. Value of transient elastography for the prediction of varicealbleeding / I.Sporea, I.Ratiu, R.Sirli et al. // World J. Gastroenterol. - 2011. - Vol.17, № 17. -P. 2206-2210.274.Svoboda, P.
A different view of acute upper gastrointestinal bleeding in livercirrhosis patients / P.Svoboda, J.Ehrmann, P.Klvana et al. // Vnitmi Lekarstvi. 2010. - Vol. 56, № 11. — P. 1116-1121.275.Thabut, D. Diagnostic performance of Baveno IV criteria in cirrhotic patientswith upper gastrointestinal bleeding: analysis of the F7 liver-1288 studypopulation / D.Thabut, G.DAmico, P.Tan et al.
// J. Hepatol. - 2010. - Vol. 53, №6. - P. 1029-1034.276.Таске, F. Serum chemokine receptor CXCR3 ligands are associated withprogression, organ dysfunction and complications of chronic liver diseases /F.Таске, H.W.Zimmermann, M.L.Berres et al. // Liver Int. - 2011. - Vol. 31, №6. - P. 840-849.277.Tajiri, T. Long-term results of modified distal splenorenal shunts for thetreatment of esophageal varices / T.Tajiri [et al.] // Hepatogastroenterology. –2000. – Vol. 47, № 33. – P.
720-723.278.Takamatsu, M. Obstructive jaundice caused by a portal cavernoma /M.Takamatsu, M.Furutake, T Hisa, M.Ueda // Jap. J. Radiol. - 2010. - Vol. 28, №10. - P. 754-758.279.Teltschik, Z. Intestinal bacterial translocation in rats with cirrhosis is relatedto compromised Paneth cell antimicrobial host defense / Z.Teltschik, R.Wiest,J.Beisner et al. // Hepatology. - 2012. - Vol. 55, №4. - P. 1154-1163.280.Thevenot, T. Is this really the end of beta-blockers in patients with cirrhosisand refractory ascites? / T.Thevenot, J.P.Cervoni, E.Monnet et al. // Hepatology.- 2011.
- Vol. 53, №2.-P.715-716.134281.Tsiakalos, A. Portopulmonary hypertension and serum endothelin levels inhospitalized patients with cirrhosis / A.Tsiakalos, G.Hatzis, I.Moyssakis et al. //Hepatobil. Pancreat. Dis. Int. - 2011. - Vol. 10, № 4. - P. 393-398.282.Uravic, M. Portasystemic shuntour twenty years experience / M.Uravic [et al.]// Zentralbl. Chir. – 2002.
– Vol. 127, № 11. – P. 971-974.283.Varghese, J. Predictors of variceal bleed among patients with liver, cirrhosisin the era of sclerotherapy / J.Varghese, J.V.Cherian, R.Solomon // SingaporeMed. J. - 2008. - Vol. 49, № 3. - P. 239-242.284.Warren, W.D. Selective transplenic decompression of gastroesophagealvarices by distal splenorenal shunt / W.D.Warren, R.Zeppa, J.Foton // Ann.
Surg.- 1967. - Vol.166. – P.437.285.Whiple, A.O. The problem of portal hypertension in relation to thehepatosplenopathies / A.O.Whiple // Ann. Surg. - 1945. - Vol. 122, №4. - P. 449.286.Witters, Р. Noncirrhotic presinusoidal portal hypertension is common incystic fibrosis- associated liver disease / P.Witters, L.Libbrecht, T.Roskams et al.// Hepatology.
-2011.-Vol. 53, № 3. - P. 1064—1065.287.Wolff, M. Current state of portosystemic shunt surgery / M.Wolff, A.Hirner //Langenbecks. Arch. Surg. - 2003. - Vol. 388, №3.-P. 141-149.288.Wolff, M. Surgical treatment of portal hypertension / M.Wolff, A.Hirner //Zentralbl. Chir. –2005. - Vol. 130, №3. – Р. 238-245.289.Yang, L.
Two surgical procedures for esophagogastric variceal bleeding inpatients with portal hypertension / L.Yang, L.Yuan, R.Dong // World JGastroenterol. -2013. - Vol. 19, №48. – Р. 9418-9424.290.Yao, H.S. Randomized clinical trial of vessel sealing system (LigaSure) inesophagogastric devascularization and splenectomy in patients with portalhypertension / H.S.Yao, W.J.Wang, Q.Wang et al. // Am. J. Surg. - 2011.
- Vol.202, № l . - P . 82-90.291.Yin, L. The surgical treatment for portal hypertension: a systematic reviewand meta-anaysis / L.Yin, H.Liu, Y.Zhang et al. // ISRN Gastroenterol. – 2013. 464053 http: // dx. doi. org / 10.1155/ 2013/ 464053.135292.You, L.Y. Clinical application of the transjugular intrahepatic portosystemicstent-shunt in the emergency treatment of esophagogastric varices bleeding dueto cirrhosis / L.Y.You, Y.C.Li, D.Yan et al.
// Chung Hua Kan Tsang Ping TsaChih. - 2011. - Vol. 19, № 7. - P. 490-493.293.Zhang, Z.T. On Surgical manangment of portal hypertension due to livercirrhosis at era evidence - based medicine / Z.T.Zhang //Cgin. J. HepatobiliarySurg. (Chin). –2008. - Vol. 14. – Р. 77-78.294.Zharg, D. Reticulon 4B (Nogo-B) is a novel regulator of hepatic fibrosis /D.Zharg. Р.Utsumi, H.C.Huang et al. // Hepatology. - 2011. - Vol. 53, № 4.
- P.1306—1315.295.Zoli, M. Prognostic significance of portal hemodynamics in patients withcompensated cirrhosis / M.Zoli, T.Iervese, С.Merkel et al. // J. Hepatol. – 1993. Vol. 17. – Р. 56..